Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 2,854 | 2,412 | 2,848 | 2,027 | 795 |
| Gross Profit | 2,854 | 2,412 | 2,848 | 2,027 | 795 |
| Operating Expenses | 17,056 | 18,254 | 13,527 | 9,945 | 8,605 |
| Operating Income | -14,202 | -15,842 | -10,679 | -7,918 | -7,810 |
| Other Income | 2 | 3 | 5 | 6 | 3 |
| Pre-tax Income | -14,200 | -15,839 | -10,674 | -7,912 | -7,807 |
| Net Income Continuous | -14,200 | -15,839 | -10,674 | -7,912 | -7,807 |
| Net Income | $-14,200 | $-15,839 | $-10,674 | $-7,912 | $-7,807 |
| EPS Basic Total Ops | 10.81 | -0.80 | -7.69 | -6.49 | -8.05 |
| EPS Basic Continuous Ops | 10.81 | -0.80 | -7.69 | -6.49 | -8.07 |
| EPS Diluted Total Ops | 10.81 | -0.80 | -7.69 | -6.49 | -8.05 |
| EPS Diluted Continuous Ops | 10.81 | -0.80 | -7.69 | -6.49 | -8.07 |
| EBITDA(a) | $-13,060 | $-14,786 | $-10,018 | $-7,449 | $-7,414 |